RK-287107
CAS No. 2171386-10-8
RK-287107( —— )
Catalog No. M23984 CAS No. 2171386-10-8
RK-287107 is an effective and specific inhibitor of tankyrase (IC50s: 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | In Stock |
|
| 10MG | 282 | In Stock |
|
| 25MG | 531 | In Stock |
|
| 50MG | 767 | In Stock |
|
| 100MG | 1053 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRK-287107
-
NoteResearch use only, not for human use.
-
Brief DescriptionRK-287107 is an effective and specific inhibitor of tankyrase (IC50s: 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively).
-
DescriptionRK-287107 is an effective and specific inhibitor of tankyrase (IC50s: 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively).
-
In VitroRK-87107 (0.01-10 μM; 12 hours) shows an antiproliferative effect on colorectal cancer cells harboring short adenomatous polyposis coli (APC) mutations. The 50% growth inhibition (GI50) value of RK-287107 on COLO-320DM cells is 0.449 μM. RK-287107 (0.03-10 μM; 16 hours) causes accumulation of tankyrase and Axin1/2. RK-287107 (0.03-10 μM; 16 hours) also downregulates β-catenin signaling in cultured cells. Cell Proliferation Assay Cell Line:Colorectal cancer COLO-320DM, SW403, RKO, HCC2998, HCT-116, and DLD-1 cells Concentration:0.01, 0.1, 1, 10 μM Incubation Time:12 hours Result:Inhibited the growth of APC-mutated (β-catenin-dependent) colorectal cancer COLO-320DM and SW403 cells. The GI50 value of RK-287107 on COLO-320DM is 0.449 μM. Did not inhibit the growth of APC-wild (β-catenin-independent) colorectal cancer cell lines, including RKO, HCT-116, HCC2998 and DLD-1. Western Blot Analysis Cell Line:COLO-320DM cells Concentration:0.03, 0.1, 0.33, 1, 3, and 10 μM Incubation Time:16 hours Result:Downregulation of active β-catenin was observed
-
In VivoRK-287107 (100 and 300 mg/kg; i.p. administration; once per day; 5-days on/ 2-days off schedule for 2 weeks) inhibits tumor growth in a mouse xenograft model. Animal Model:6-week-old female NOD.CB17-Prkdcscid/J mice with colorectal cancer COLO-320DM Dosage:100 and 300 mg/kg Administration:Administration i.p.; once per day; 5-days on/ 2-days off schedule for 2 weeks Result:100 and 300 mg/kg resulted in 32.9% and 44.2% TGI, respectively.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptortankyrase 1|tankyrase 2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2171386-10-8
-
Formula Weight416.46
-
Molecular FormulaC22H26F2N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:120 mg/mL (288.14 mM; Need ultrasonic)
-
SMILESOCCN(C1)c2cc(F)cc(F)c2C1(CC1)CCN1C(N1)=NC(CCCC2)=C2C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mizutani A, et al. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. Cancer Sci. 2018 Dec;109(12):4003-4014.
molnova catalog
related products
-
Hydroumbellic acid
Hydroumbellic acid is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 3-(2, 4-dihydroxyphenyl)prop-2-enoic acid.
-
Tilmicosin
Tilmicosin is a macrolide antibiotic.
-
S100P-IN-1
S100P-IN-1 is a potent S100P inhibitor.S100P-IN-1 has anti-metastatic effects on pancreatic cancer (pancreatic) cells.
Cart
sales@molnova.com